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1. Introduction 
Amyloidosis refers to a group of protein misfolding diseases characterized by deposition of 
a particular amyloid protein in various organs and tissues of animals and humans. 
Although there are other components present in the deposit, the amyloid protein fibril is the 
main component of the amyloid substance. The amyloid substance differs in protein 
composition depending upon the types of amyloidosis (AA amyloidosis or AL amyloidosis) 
and the different clinical forms. Each clinical entity or form of amyloidosis may be 
manifested by a distinct clinical form with chemically specific amyloid fibril protein. This 
indicates that amyloid is a biochemically heterogeneous substance, although there are 
similarities in properties and staining characteristics. 
Amyloidosis involving several tissues and organs throughout the body is referred to as 
systemic amyloidosis. This may be AA amyloidosis (including familial amyloidosis) or AL 
amyloidosis. Systemic amyloidosis can be deposited in several vital organs and tissues and 
may entail severe damage. Amyloid substance may be confined at a given area in the body 
in the form of localized amyloidosis.  
The pathogenesis, pathology and clinical presentations of amyloidosis are protean 
consequent to the diverse underlying causes of its various forms, species of animals affected 
and the severity of functional disruption in different tissues and organs involved. The 
diagnosis of amyloidosis requires histopathologic identification of amyloid deposits in the 
affected tissues. This is confirmed by Congo red staining and green birefringence under 
polarized light. 
In this chapter, the pathology, pathogenesis, lesions, and clinical syndromes encompassing 
various forms of amyloidosis in animals will be covered. Current knowledge available on 
amyloidosis in animals, which would be of importance as a reference for veterinary 
professionals and practitioners, and veterinary students will be elucidated in the chapter.  
2. Pathology and pathogenesis 
The pathology and pathogenesis of amyloidosis is a captivating enigma consequent to the 
diverse underlying causes of its various forms in different species affected. About 20-25 
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different types of proteins with the ability to aggregate, insolubilize, and deposit in tissue as 
amyloid have been identified (Murphy et al., 2001, Gruys, 2004).  In animals, at least eight 
different amyloid precursors have been described (Ménsua et al., 2003). The precursor 
proteins in amyloid fibrils may be amyloidogenic mutants as in some familial amyloidosis, 
whereas other precursors are normal wild-type proteins (Westermark, 1998; Gruys, 2004). 
The exact mechanisms through which the proteins are converted into amyloid fibrils in vivo 
are not well known (Westermark, 1998). There are a number of divers conditions that can be 
associated with the formation of amyloid and each of these conditions are characterized by 
excessive production of amyloidogenic proteins that are prone to misfolding.  Under normal 
conditions, the misfolded proteins are enzymatically degraded intracellularly within 
proteasomes or extracellularly by macrophages. In amyloidosis, these degradative processes 
are inadequate and may be responsible for the accumulation of misfolded protein 
extracellularly. The overproduction of precursor protein, although necessary, is not 
sufficient to result in the formation of amyloid by itself (Snyder, 2007). A single 
amyloidogenic protein may result in multiple forms of amyloid fibrils depending on their 
induction conditions. Multiple mechanisms for amyloidogenesis are expected to operate as 
witnessed with their fibrillar polymorphism (Bhak et al., 2009). Although there are divers 
proteins associated with the formation of amyloid, they are all characterized by misfolded 
proteins leading to the formation of fibrils that are unstable and self associated (Snyder, 
2007). The protein fibril is the main component of the amyloid substance, however, there are 
other components present, the importance of which is yet not well established in the 
pathogenesis of amyloidosis. All forms of amyloid contain the pentraxin glycoprotein 
amyloid P-component (AP) that most probably is bound to the protein fibrils directly. The 
unique -sheet fibril of amyloid is very resistant to physical agents and also gives the 
amyloid substance many of its characteristic properties, including affinity to the dye Congo 
red and green birefringence under polarized light after such staining (Westermark, 1998).   
According to the WHO-IUIS Nomenclature Sub-Committee (1993) on the nomenclature of 
amyloid and amyloidosis, amyloid and amyloidosis are classified based on the amyloid 
fibril protein, followed by a designation of the fibril protein precursor. The capital letter A 
for amyloid is followed by the protein designation in abbreviated form. For example AL-
amyloid refers to the amyloid derived from immunoglobulin light chain, whereas AA-
amyloid refers to the amyloid derived from serum A-amyloid protein.  Amyloid fibrils may 
be deposited locally in a given tissue (local amyloidosis) or it may be a systemic deposit 
(systemic amyloidosis) involving various tissues and organs in the body. Systemic deposits 
of amyloid are recognized as AL-amyloidosis (primary amyloidosis), AA-amyloidosis 
(secondary or reactive amyloidosis) or familial amyloidosis. 
2.1 AA – Amyloidosis 
AA-amyloidosis is described in literature as reactive or secondary amyloidosis. It is the most 
common form of amyloidosis in domestic animals. AA amyloidosis is associated with 
chronic inflammatory or neoplastic diseases (non-immunocyte dyscrasia) or it may be 
idiopathic, where no underlying disease is found (Kim et al., 2005; Snyder, 2007). In this 
form of amyloidosis, the deposited amyloid protein is derived from serum amyloid-A 
synthesized in the liver (Kim et al., 2005).  Amyloid A is derived from the acute phase 
reactant, serum amyloid A (SAA) (Kisilevsky, 1990; Gruys, 2004), which is an apolipoprotein 
of high-density lipoproteins (HDL), classes 2 and 3. It is formed mainly in the liver upon 
www.intechopen.com
Amyloidosis in Domestic Animals:  
Pathology, Pathogenesis, Gross and Microscopic Lesions and Clinical Findings 
 
151 
stimulation by pro-inflammatory cytokines (Gruys, 2004) and normally plays a role in 
cholesterol transport (Kisilevsky, 1990) and as a chemoattractant (Badolato et al., 1994) in the 
inflammatory processes. When the concentration of this molecule is increased, typically as a 
result of chronic inflammation, certain isoforms of SAA are partially cleaved into fragments 
that have an increased propensity to form fibrillar aggregates of amyloid that are deposited 
systemically, mainly in the kidney, liver, and spleen (Johnson et al., 1996).  In systemic AA 
amyloidosis (reactive systemic amyloidosis), macrophages are known to be activated and 
elaborate endogenous pyrogens IL-1 and IL-6, which stimulate hepatocytes to synthesize 
and secrete SAA. During an inflammatory reaction, the quantity of SAA in the serum may 
increase several 100 times normal concentrations. However, not all systemic inflammatory 
reactions lead to the formation of AA amyloid; but only some of the inflammatory reactions 
lead to amyloidosis.  Either an enzyme defect in the system that normally degrades SAA 
protein or the synthesis of abnormal SAA protein that is resistant to the enzymatic 
degradation is suggested to underlie production of insoluble AA molecules that form the 
amyloid fibrils (Snyder, 2007). Some species of animals appear to have genetic 
predisposition to the deposition of AA amyloidosis. Analysis of SAA cDNA sequences from 
several animals identified a distinct genetic dimorphism that may be relevant to the 
susceptibility to secondary amyloid disease. The duck genome contained a single copy of 
the SAA gene that was expressed in the liver and lung tissues of ducklings, even in the 
absence of induction of acute phase response (Guo et al., 1996). Siamese and Abyssinian cats 
and Shar Pei dogs appear to have familial predisposition of AA proteins with different 
primary sequence and pattern of deposition in the body (Boyce et al., 1984; DiBartola et al., 
1986 & 1990). Amyloid resistant mouse strains were found to have a non-amyloidogenic 
acute phase SAA (Gonnerman et al., 1995; Liang et al., 1998). Rats were shown not to form 
acute phase SAA and AA-amyloid at all (Ren et al., 1999; Yu et al., 2000). 
AA amyloidosis is the most common type of amyloid in mammals and birds (Fig. 1) and 
often results in hepatic or renal failure due to physical disruption of normal cellular and 
organ processes (Terio et al., 2008).  It is a common disease of water fowl and is 
characterized by the deposition of extracellular fibrils of amyloid A (AA) protein in the liver 
and certain other organs in this species (Guo et al., 1996). AA amyloidosis is also reported in 
a wide variety of domestic animal species including canines, equines, bovines, avian species, 
porcines, felines, sheep and goats (Jakob, 1971; Johnson & Jamison, 1984; Hayden et al., 1988; 
Zschiesche & Jakob, 1989; DiBartola, et al., 1990; Blunden & Smith, 1992; Seifi et al., 1997; 
Landman, 1998; Ménsua et al., 2003).  It is described in association with different chronic 
diseases, in captive cheetah (Acinonyx jubatus), Siberian tigers (Panthera tigris altaica), mink 
(Mustela vison), black-footed cats (Felis nigripes), black-footed ferrets (Mustela nigripes),  
Dorcas gazelle (Gazella dorcas), mountain gazelle (Gazella gazella), bighorn and Dall’s sheep, 
free living lioness  and in swans and other anatidae (Panthera leo) (Hadlow & Jellison, 1962; 
Sato et al., 1981; Kingston et al., 1982; Linke et al., 1986; Rideout et al., 1989; Munson, 1993; 
Nieto et al., 1995; Papendick et al., 1997; Schulze et al., 1998; Williams et al., 2005; Garner et 
al., 2007; Terio et al., 2008). It is reported in association with chronic lymphoplasmacytic 
gastritis in the cheetahs and as idiopathic in the Siberian tigers. In the cheetahs and the 
Siberian tigers, the deposits were primarily in the medullary interstitium, with minimal 
glomerular involvement (Papendick et al., 1997; Schulze at al., 1998). Deposition of the 
amyloid in renal amyloidosis reported in the Dorcas gazelle was also mainly in the renal 
medulla, sparing the glomeruli (Rideout et al., 1989). 
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Fig. 1. A section of liver with hepatic amyloidosis in an American Coot with severe 
parasitism. (A) Light eosinophilic amorphous deposits disrupted the hepatic parenchyma 
(H&E stain). The deposit stained light red with Congo red stain (B) and exhibited green 
birefringens under polarized light (C). The amyloid deposit failed to stain with Congo red 
(D) after pretreatment with Potassium Permanganate solution, characteristic of AA-
amyloid. 
2.1.1 Familial forms of AA amyloidosis 
Familial amyloidosis refers to the deposition of amyloid in tissues of animals in a given 
genetically associated family known to be prone to the deposition of amyloid fibrils.  In 
veterinary medicine, it is reported in Siamese and Abyssinian cats (Boyce et al., 1984; 
DiBartola et al., 1986 & 1990) with the AA proteins differing in primary sequence and 
pattern of deposition in these cats (DiBartola et al., 1986 & 1990). Familial amyloidosis is also 
reported in Shar Pei dogs (DiBartola et al., 1990). The kidney is the main target organ for the 
deposition of amyloid in the Abyssinian cat, and Shar Pei dogs, while the amyloid protein is 
mainly deposited in the liver in Siamese cats (DiBartola et al., 1986 & 1990; Niewold et al., 
1999).   Furthermore, there are other animal species that appear to be prone to amyloid 
deposition. The high prevalence of amyloidosis in captive cheetahs is suggested to indicate 
some level of familial predisposition similar to the Abyssinian cats (Papendick et al., 1997). 
Amyloid arthropathy frequently occurred in brown layer chickens, but never in white 
layers. The suspected higher susceptibility of brown layers was confirmed experimentally 
by inducing amyloidosis with an arthropathic and amyloidogenic strain of E. faecalis 
(Ovelgönne et al., 2001). In the systemic amyloidosis reported in the black-footed cats, there 
was no association with concurrent chronic inflammatory conditions, indicating that the 
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amyloid deposit was not secondary to inflammation. Heritability estimation suggested that 
amyloidosis might be familial in this species. Additionally, tissues from a single free-
ranging black-footed cat had small amounts of amyloid deposition, suggesting that there 
could be a predilection for amyloidosis in this species too (Terio et al., 2008). Therefore, in 
addition to Siamese and Abyssinian cats and Shar Pei dogs, in which familial amyloidosis is 
well-recognized in veterinary medicine, certain species such as cheetahs (Acinonyx jubatus), 
Dorcas gazelles (Gazella dorcas), black-footed cat and brown layer chickens appear to be 
genetically predisposed to amyloidosis. 
2.2 AL – Amyloidosis 
The AL amyloid type derived from immunoglobulin light chains is the most common form 
of systemic amyloidosis in humans (Picken, 2001). Small-sized bone marrow plasma cell 
clones are reported to produce toxic light chains that cause fibrillar deposits in multiple 
organs (Merlini & Stone, 2006).  The amyloid fibrils are formed by the N-terminal fragment 
of a monoclonal immunoglobulin light chain comprising the variable region and a portion 
of the constant region. Only a small proportion of free monoclonal light chains form 
amyloid fibrils in vivo. Thus, the ability to form amyloid is probably related to individual 
structural characteristics of the light chain variable region. Unlike most other plasma cell 
dyscrasias, the  light chain isotype is prevalent in AL (/ ratio, 1:3), suggesting the 
existence of amyloid-associated V germ line genes (Merlini & Stone, 2006).   
AL amyloidosis is very rare in domestic animals (Kim et al., 2005), unlike in humans, in 
which it is a common form of systemic amyloidosis. Report on systemic AL amyloidosis in 
domestic animals is very rare. It is reported in a horse gelding with multiple myeloma (Kim 
et al., 2005), a mare (Hawthorne et al., 1990) and in a cow with bovine leukocyte adhesion 
deficiency (Taniyama et al., 2000). Recently, non-AA amyloid is reported in two felines with 
thymomas (Burrough et al., 2011). In animals, the deposition of AL amyloid protein is 
generated following overproduction of monoclonal light chains associated with 
immunocyte dyscrasia. In this form of amyloidosis, plasma cells produce excessive 
quantities of immunoglobulin light chains that are resistant to complete enzymatic 
degradation and are susceptible to forming insoluble fibrils (Snyder, 2007). The most 
common immunocyte dyscrasia associated with AL amyloidosis in domestic animals is a 
neoplasm of plasma cell. The AL form of amyloid can contain complete immunoglobulin 
light chains, the NH2-terminus portion of immunoglobulin light chains or both. 
Immunoglobulin secreting cells, B lymphocytes, and plasma cells are associated with the 
deposition of AL amyloid.  In contrast to amyloidosis in humans, in which the majority of 
patients with AL do not have any overt B lymphocyte or plasma cell neoplasm, but do have 
monoclonal antibodies or light chains in their serum or urine, domestic species rarely have 
AL-type amyloid without evidence of an immune dyscrasia (Snyder , 2007).   
2.3 Localized and other forms of amyloidosis 
Localized amyloidosis refers to the deposition of amyloid fibrillar protein as a grossly 
visible mass or a microscopic deposit at a given site in an organ or tissue. Localized AL is an 
intriguing condition characterized by limited growth of monoclonal plasma cells and 
restriction of amyloid deposits to sites adjacent to those of the synthesis of the precursor 
(Merlini & Stone, 2006).  In animals, localized amyloidosis is present in calcifying epithelial 
odontogenic tumors (amyloid producing odontogenic tumors) of the cat and dog and 
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pancreatic islets in cats (Gruys, 2004; Snyder, 2007). A-amyloid and APrPsc-amyloid can be 
encountered in the brains of old dogs and sheep with scrapie, respectively (Prusiner et al., 
1983; Gruys, 2004). Some forms of naturally occurring transmissible spongiform 
encephalopathies such as chronic wasting diseases (CWD), are characterized by amyloid 
plaques in the brain in addition to the intraneural vacuolation (Snyder, 2007). In horses, 
localized cutaneous amyloidosis is described in association with lymphoma (Gliatto & 
Alroy, 1995), extramedullary plasmacytoma (Linke et al., 1991) and liver amyloidosis in 
serum-producing horses (Abdelkadir, et al., 1991). Local amyloidosis associated with 
plasma cell dyscrasia or focal extramedullary plasmacytoma occurs on the skin and along 
intestinal tracts in dogs (Fig. 2). 
 
 
Fig. 2. A section of colon with amyloidosis in a dog with focal intestinal extramedullary 
plasma cell tumor. (A) Light eosinophilic amorphous deposits (D) surrounded by abundant 
plasmacytoid cells (H&E stain). The deposit stained light red with Congo red stain (B) and 
exhibited green birefringence under polarized light (C). The amyloid deposit stained with 
Congo red (D) after pretreatment with Potassium Permanganate solution, indicating that 
the amyloid is AL-amyloid. 
Deposition of amyloid derived from islet amyloid polypeptide (IAPP), a normal protein 
secreted by the  cell of the pancreas, is reported in the pancreas of cats, and macaques. The 
mechanisms by which IAPP, a normal product of pancreatic islet beta cells, undergoes 
assembly and transformation into deposits of amyloid fibrils are not fully understood 
(O’Brien et al., 1996; Hoenig et al., 2000). However, the islet amyloid deposits in humans and 
feline and macaque animal models of type 2 diabetes mellitus are associated with significant 
loss of islet  cells (Hoenig et al., 2000). It is not known if the deposition of amyloid and the 
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development of clinical diabetes mellitus is the result of progressive loss of  cells from the 
amyloid deposit or if the deposition of the amyloid occurs as a result of prolonged 
stimulation of the  cells as a consequence of insulin resistance (Snyder, 2007). 
Similar to human senile amyloidosis, old dogs develop neurodegenerative brain changes 
including cerebrovascular amyloidosis and senile plaques with amyloid deposition. The 
amyloid protein in the canine cerebrovascular amyloidosis is deposited in the medium- and 
small-caliber arterioles and capillaries of the leptomeninges and the brain parenchyma.  
Vascular or perivascular degeneration or cellular reactions were not detected in affected 
vessels (Borra’s et al., 1999).  Such amyloid deposits in the brain consist of a number of 
extracellular proteins, but most commonly contain A type amyloid, which consists of a 
proteolytic fragment of the APP (Amyloid Precursor Protein). The A form of amyloid is 
associated with the cerebral amyloid angiopathy of Alzheimer’s disease in humans and with 
neurodegeneration in the canine brain (Snyder, 2007). In the brain tissue of aged dogs, 
Alzheimer-like pathology with lipofuscin being present in neurons and macrophages, Aβ-
precursor protein in neurons, Aβ-positive plaques, 4-hydroxynonenal in neurons and 
macrophages, and limited intraneuronal accumulation of tau and advanced glycation end 
products increasing with longevity has been encountered (Gruys, 1995; Papaioannou et al., 
2001; Rofina et al., 2001 & 2003). The amyloidosis which causes neurodegenerative disorders 
is almost always related to the intracerebral production of the pathogenic protein since most 
proteins, like immunoglobulins, do not cross the blood brain barrier. One exception may be 
the case of systemic amyloidosis related to transtiretin mutations, which produce peripheral 
neuropathy and cerebral changes in the white matter in some cases (Mena, 2009).  
Aβ-amyloid in the brain tissue of aged dogs showing signs of dementia forms a canine 
counterpart of senile dementia of the Alzheimer type (ccSDAT) in man. Other organ systems 
containing amyloid in the aged dog are the heart, gastrointestinal tract, and lungs. The 
deposition of amyloid in the pulmonary vasculature of the aged dogs was reported to be 
derived from apolipoprotein AI (Apo AI) (Snyder, 2007).  
3. Clinical findings 
Amyloidosis is a feature of several different pathologic mechanisms and as such should 
not be considered a single disease, but rather a group of diseases having in common the 
deposition of similar appearing proteins (Snyder, 2007). The animals affected with 
amyloidosis may show variable clinical signs due to the main underlying disease as 
commonly seen in  AA amyloidosis (secondary amyloidosis ) or those solely attributable 
to the deposition of amyloid in a given tissue or both.  Some local amyloid depositions 
may be clinically non-significant incidental findings in certain tissues. In most cases, small 
local cutaneous amyloid masses pose no clinical problems. Therefore, the clinical finding 
of amyloidosis in affected animals is protean and reflects the extent of perturbed function 
of the predominantly affected organs and tissues due to the deposition of amyloid or may 
show variable clinical signs that may be associated to the underlying chronic disease and 
the concurrent amyloid deposit. For example, kidney is the main target organ for the 
deposition of amyloid in familial amyloidosis of the Abyssinian cat (glomerular deposit), 
and Shar Pei dogs (medullary deposit), while the amyloid is mainly deposited in the liver 
in Siamese cats (DiBartola et al., 1990; Niewold et al., 1999). Because amyloid deposit in 
the amyloidosis of the Abyssinian cat and Shar Pei dog is primarily a renal deposit, 
clinical signs associated with disrupted renal function will be seen in the affected 
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Abyssinian cats, and Shar Pei dogs, whereas clinical signs associated with derailed 
hepatic function may be manifested in Siamese cats. Deposition of amyloid in the 
pancreas of cats, non-human primates (macaques and baboons) and humans can lead to 
the development of type 2 diabetes mellitus (Hoenig et al., 2000; Snyder, 2007). Amyloid 
deposition can also occur in the cortex of the adrenal gland; however, it is not associated 
with any functional deficiencies (Snyder, 2007).   
Reactive systemic amyloidosis secondary to chronic inflammatory conditions is often the 
most severe of the systemic forms. Liver, kidneys, spleen, lymph nodes, and adrenal glands 
are most commonly affected.  Animals with renal amyloidosis frequently die from renal 
failure (Snyder, 2007). The clinical sign usually reflects the functional disruption and 
severity of the particular site of the kidney affected in renal amyloidosis. Progressive renal 
failure was the cause of death in Dorcas gazelles with renal medullary amyloidosis (Rideout 
et al., 1989). In contrast, renal medullary amyloidosis in cattle frequently occurs in 
conjunction with glomerular amyloidosis, and if the glomerular component is mild, it is 
usually a subclinical disease (Gruys, 1980, as cited by Rideout et al., 1989.) In Dorcas gazelle 
impairment of the renal function involved obstruction of the medullary tubules and 
collecting ducts, leading to atrophy and eventual loss of nephrons, with progressive 
interstitial fibrosis in the medulla and cortex (Rideout et al., 1989).  Interstitial amyloidosis 
may also contribute to loss of concentrating ability and renal failure by interfering directly 
with maintenance of the medullary interstitial concentration gradient necessary for 
reabsorptive function in the renal tubules (Papendick et al., 1997). In 74% of the cheetahs 
with systemic amyloidosis associated with chronic gastritis, renal failure was determined to 
be the sole or partial cause of death (Papendick et al., 1997). Clinical signs including rapid 
weight loss, muscle atrophy, soft unformed stool, and ventral edema were noted in a horse 
gelding with multiple myeloma (Kim et al., 2005).  
4. Gross and microscopic lesions 
Several different pathologic mechanisms and conditions underlie various forms and 
types of amyloidosis, although abnormal proteins with similar staining characteristics 
are deposited in various organs and tissues of the affected animals. The gross feature of 
amyloidosis due to the deposited amyloid in these tissues and organs is not specific for 
amyloid. Grossly, the affected organs are often enlarged, moderately firm and 
abnormally discolored (Snyder, 2007). In AA-amyloidosis, the most frequently 
encountered amyloid type in veterinary medicine, the characteristic deposition pattern in 
most species is in the central organs such as spleen, liver, enteric mucosa and the arterial 
walls (Gruys, 1988 as cited by Gruys, 2004). Depending on the extent of the deposition, 
there may be splenomegaly, hepatomegaly and renomegaly as these organs are most 
commonly affected in systemic AA amyloidosis. Amyloid deposition was most severe in 
the renal medullary interstitium and glomeruli in systemic amyloidosis in black-footed 
cats (Terio et al., 2008). Renal lesions in AA amyloidosis in sheep and goats were 
characterized grossly by pale cortical surfaces with scattered, miliary, whitish-yellow 
foci and by straight, whitish-yellow striations on cut cortical surfaces (Ménsua et al., 
2003). However, experimentally induced AA Amyloidosis in sheep principally affected 
the gastrointestinal tract. Amyloid was present from the tongue to the rectum, but was 
most prominent in the duodenum where the deposits disrupted the normal mucosal 
architecture. Other body organs had only mild amyloid deposition (Biescas et al., 2009). 
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Diffuse gastrointestinal hemorrhage, markedly thickened jejunal mucosa, and 
splenomegaly were present in a horse with AL amyloidosis associated with multiple 
myeloma (Kim et al., 2005). In Gallinae, it may also be deposited in the joints. In felines, 
pancreatic insular amyloid (AIAPP) is rather common (Gruys, 1988, as cited by Gruys, 
2004). Amyloid deposits are occasionally limited to a single organ or tissue and may be 
visible grossly as masses (Snyder, 2007). Local amyloid deposits associated with plasma 
cell dyscrasia may be seen as variably sized grossly visible skin granulomas in cutaneous 
nodular amyloidosis in various animals. Rowland et al., (1991) reported local cutaneous 
amyloidosis associated with plasmacytoma involving the digits, forelimbs, lips, and ears 
in dogs (Fig. 3). 
 
 
Fig. 3. Histological features of skin of a dog with nodular cutaneous amyloidosis, stained 
red with Congo red stain (left) and showed yellow-green birefringence (right) illuminated 
with polarized light, characteristic of amyloid deposits. 
Microscopic findings of the deposition of amyloid protein may correspond to the grossly 
visible lesions, or it may be seen only after microscopic examination without distinct 
grossly discernible lesions. Amyloid should be differentiated from other similar-
appearing extracellular deposits such as collagen and fibrin (Snyder, 2007). For a fibrillary 
protein to be considered amyloidogenic it should produce extracellular deposits with 
affinity for the red Congo dye and a green birefringence under polarized light. Congo red 
stain, which does not have chemical specificity for amyloid, but is dependent on the 
conformational property of being arranged in beta-pleated sheets, is the most commonly 
used stain for the identification of amyloid. Amyloid stains orange to red under light 
microscopy, which is seen under polarized light as an apple-green birefringent material 
(Ménsua et al., 2003; Snyder, 2007). Immunohistochemistry can also be used not only to 
identify amyloid deposits but also to identify the specific constituents composing the 
deposits such as the anti--light chain antibodies (Snyder, 2007). AA and AL amyloid 
deposits stain similar with Congo red stain. The identification of AA is usually based on 
its reactivity with specific anti-AA antibodies and sensitivity to permanganate 
pretreatment (Wright et al., 1977; Shtrasburg et al., 2005) (Fig. 4). The common ultra 
structure of amyloid proteins is made of some nonbranching, rigid fibrils, 7.5 to 10 nm 
wide and of variable length, which arrange themselves in anti-parallel sheets with β 
structure (Mena, 2009). 
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Fig. 4. A section of renal glomerular amyloidosis in a dog. (A) Light eosinophilic amorphous 
deposits partly effaced the glomerular architecture (H&E stain). The deposit stained light 
red with Congo red stain (B) and exhibited green birefringence under polarized light (C). 
The amyloid deposit failed to stain with Congo red (D) after pretreatment with Potassium 
Permanganate solution, indicating that the amyloid is AA-amyloid. 
Microscopically, amyloid is deposited extracellularily in various affected tissues. Amyloid 
deposition was seen in the kidneys, blood vessels, spleen, liver, lymph nodes, gastrointestinal 
tract, and adrenal glands of sheep and goats with AA amyloidosis (Ménsua et al., 2003). There 
was widening of the medullary interstitium by eosinophilic homogeneous material, which 
encroached upon medullary tubules and collecting ducts with occasional renal papillary 
necrosis in Dorcas gazelle with medullary amyloidosis. The amyloid deposition significantly 
correlated with interstitial fibrosis, and tubular dilation and atrophy (Rideout, 1989). 
In a horse with AL amyloidosis associated with multiple myeloma, diffuse severe 
extracellular amyloid deposits were present in the lamina propria of glandular stomach, 
duodenum, and jejunum. Much of the spleen and sternal bone marrow were replaced by 
neoplastic round cells, and multiple foci of amyloid were also present in the spleen and 
bone marrow. No significant microscopic changes were noted in the kidneys, liver, and 
lungs (Kim et al., 2005).  
In a cow with systemic AL amyloidosis associated with bovine leukocyte adhesion 
deficiency, amyloid deposits immunohistochemically related to immunoglobulin kappa-
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light chains of precursor protein were present in the perivascular and intercellular spaces of 
the visceral organs, such as the liver, kidneys, pancreas, adrenal glands, and upper 
alimentary tract (Taniyama et al., 2000). 
5. Conclusion 
In summary, the pathology and pathogenesis of amyloidosis in animals is diverse 
depending upon the underlying causes and species affected. Similarly, the clinical findings 
are quite variable consequent to the variation of the tissues and organs involved and the 
extent of functional disruption of the affected organs in various animal species. The affected 
organs may be enlarged and exhibit variable pallor or the amyloid deposit may not be 
grossly visible and may be discernible only after microscopic examination of the affected 
tissues. Amyloid appears as a pale eosinophilic homogenous extracellular deposit in tissues. 
However, microscopic examination and Congo red staining with green birefringence under 
polarized light are needed to confirm amyloid and differentiated it from other similar 
extracellular deposits such as collagen and fibrin. Pretreatment of the affected tissues using 
potassium permanganate solution before staining with Congo red helps to differentiate AA-
amyloid from AL-amyloid deposit. 
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